Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 96, Issue 2, Pages 274-278
Publisher
Springer Nature
Online
2012-06-09
DOI
10.1007/s12185-012-1118-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe CMV reactivation and gastritis during treatment of follicular lymphoma with bendamustine
- (2011) Seah H. Lim et al. ANNALS OF HEMATOLOGY
- Reactivation of hepatitis B virus following bendamustine-containing chemotherapy in a patient with multiple myeloma
- (2011) Umit Tapan et al. LEUKEMIA & LYMPHOMA
- Pneumocystis jirovecii pneumonia as a complication of bendamustine in a patient receiving bendamustine plus rituximab for marginal zone lymphoma
- (2011) Stephanie J. Carter et al. LEUKEMIA RESEARCH
- Bendamustine: Rescue of an Effective Antineoplastic Agent From the Mid-Twentieth Century
- (2011) Lorenzo M. Leoni SEMINARS IN HEMATOLOGY
- Bendamustine for the treatment of indolent non-Hodgkin's lymphoma and chronic lymphocytic leukemia
- (2010) A. Elefante et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Bendamustine: something old, something new
- (2010) Nishant Tageja et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bendamustine
- (2010) Karly P. Garnock-Jones DRUGS
- High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma
- (2010) Izidore S. Lossos et al. LEUKEMIA & LYMPHOMA
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents
- (2009) Carlo Piccinni et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
- (2009) Peter Martin et al. JOURNAL OF CLINICAL ONCOLOGY
- Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis
- (2009) Sercan Aksoy et al. LEUKEMIA & LYMPHOMA
- Incidence of hepatitis B reactivation following Rituximab therapy
- (2008) Amr Hanbali et al. AMERICAN JOURNAL OF HEMATOLOGY
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
- (2008) C. H. Geisler et al. BLOOD
- Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study
- (2008) Jonathan W. Friedberg et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search